(PACB) Pacific Biosciences of - Performance -21% in 12m
Compare PACB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-61.98%
#38 in Group
Rel. Strength
26.00%
#5945 in Universe
Total Return 12m
-21.01%
#24 in Group
Total Return 5y
-67.46%
#35 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.17
10th Percentile in Group
FCF Yield -31.55%
(?) Percentile in Group
12m Total Return: PACB (-21%) vs XLV (0.3%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
-11.6% | -21.5% | 44.2% | 23.5 | 18.4 | 1.68 | 58.4% | 7.8% |
| RVTY NYSE Revvity |
-12.1% | -7.4% | 7.42% | 39 | 18.2 | 0.64 | -63.9% | -30.6% |
| TECH NASDAQ Bio-Techne |
-16.2% | -19.5% | -1.48% | 51.8 | 22.6 | 1.07 | -31.9% | -5.85% |
| SHC NASDAQ Sotera Health |
-6.5% | -1.46% | -55.6% | 65.6 | 20.2 | 1.68 | -43.6% | - |
Performance Comparison: PACB vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for PACB
| Total Return (including Dividends) | PACB | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -16.79% | -4.97% | -4.31% |
| 3 Months | -34.73% | -6.08% | -7.85% |
| 12 Months | -21.01% | 0.26% | 10.76% |
| 5 Years | -67.46% | 47.01% | 106.31% |
| Trend Score (consistency of price movement) | PACB | XLV | S&P 500 |
| 1 Month | -25.7% | -54.4% | -35.6% |
| 3 Months | -79.3% | -66.1% | -89.7% |
| 12 Months | -34.8% | -12% | 58.3% |
| 5 Years | -62.0% | 90% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #37 | -12.4% | -13.0% |
| 3 Month | #36 | -30.5% | -29.2% |
| 12 Month | #25 | -21.2% | -28.7% |
| 5 Years | #34 | -77.9% | -84.2% |
FAQs
Does PACB Pacific Biosciences of outperforms the market?
No,
over the last 12 months PACB made -21.01%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.26%.
Over the last 3 months PACB made -34.73%, while XLV made -6.08%.
Over the last 3 months PACB made -34.73%, while XLV made -6.08%.
Performance Comparison PACB vs Indeces and Sectors
PACB vs. Indices PACB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.5% | -12.5% | -34.1% | -31.8% |
| US NASDAQ 100 | QQQ | -13.5% | -12.6% | -34.1% | -33.0% |
| US Dow Jones Industrial 30 | DIA | -9.47% | -11.0% | -34.4% | -28.0% |
| German DAX 40 | DAX | -8.88% | -13.0% | -52.6% | -44.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.01% | -13.3% | -32.7% | -29.6% |
| Hongkong Hang Seng | HSI | -9.27% | -13.9% | -36.0% | -35.0% |
| India NIFTY 50 | INDA | -4.11% | -18.4% | -35.7% | -22.8% |
| Brasil Bovespa | EWZ | -11.3% | -18.8% | -38.6% | -15.5% |
PACB vs. Sectors PACB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.4% | -11.2% | -42.9% | -43.4% |
| Consumer Discretionary | XLY | -13.9% | -12.8% | -37.3% | -35.4% |
| Consumer Staples | XLP | -4.08% | -19.5% | -39.4% | -30.5% |
| Energy | XLE | -8.19% | -5.16% | -31.7% | -9.08% |
| Financial | XLF | -9.58% | -12.0% | -42.2% | -40.3% |
| Health Care | XLV | -8.52% | -11.8% | -32.1% | -21.3% |
| Industrial | XLI | -9.71% | -12.7% | -34.5% | -27.9% |
| Materials | XLB | -8.29% | -12.3% | -27.2% | -15.7% |
| Real Estate | XLRE | -6.71% | -14.9% | -32.0% | -36.1% |
| Technology | XLK | -15.4% | -12.3% | -29.3% | -27.3% |
| Utilities | XLU | -7.39% | -18.5% | -37.2% | -41.5% |
| Aerospace & Defense | XAR | -11.1% | -16.5% | -45.4% | -48.0% |
| Biotech | XBI | -10.7% | -8.95% | -21.0% | -18.8% |
| Homebuilder | XHB | -9.79% | -10.8% | -19.1% | -13.0% |
| Retail | XRT | -8.75% | -13.9% | -30.0% | -17.4% |